Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Finkel

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Progress in Clinical and Biological Research|January 1, 1983
Orphan products: definition and activitiesM J Finkel
Lipids|January 1, 1977
FDA considerations regarding new hypolipidemic agentsM J Finkel
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Important considerations for the clinical evaluation of drugs: appropriate dosing regimensM J Finkel
Advances in Experimental Medicine and Biology|January 1, 1972
Antilipemic drugs and the position of the FDAM J Finkel
Clinical Pharmacology and Therapeutics|February 1, 1990
The relationships of the American Society for Clinical Pharmacology and Therapeutics to governmentM J Finkel
The New England Journal of Medicine|October 7, 1982
The development of orphan productsM J Finkel
Science (New York, N.Y.)|April 20, 1979
Phenformin banM J Finkel
Progress in Clinical and Biological Research|January 1, 1985
Orphan products development and some methods for maximizing the usefulness of research on rare diseasesM J Finkel
Lancet (London, England)|June 19, 1976
Letter: Valproate in the U.S.AM J Finkel
Annals of Internal Medicine|November 1, 1978
Magnitude of antibiotic useM J Finkel
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Progress in Clinical and Biological Research|January 1, 1983
Orphan products: definition and activitiesM J Finkel
Lipids|January 1, 1977
FDA considerations regarding new hypolipidemic agentsM J Finkel
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Important considerations for the clinical evaluation of drugs: appropriate dosing regimensM J Finkel
Advances in Experimental Medicine and Biology|January 1, 1972
Antilipemic drugs and the position of the FDAM J Finkel
Clinical Pharmacology and Therapeutics|February 1, 1990
The relationships of the American Society for Clinical Pharmacology and Therapeutics to governmentM J Finkel
The New England Journal of Medicine|October 7, 1982
The development of orphan productsM J Finkel
Science (New York, N.Y.)|April 20, 1979
Phenformin banM J Finkel
Progress in Clinical and Biological Research|January 1, 1985
Orphan products development and some methods for maximizing the usefulness of research on rare diseasesM J Finkel
Lancet (London, England)|June 19, 1976
Letter: Valproate in the U.S.AM J Finkel
Annals of Internal Medicine|November 1, 1978
Magnitude of antibiotic useM J Finkel
Pageof 3